FGF21 and Cirrhosis: Enterocytes (Fig. 5): IPA analysis showed significant activation of inflammatory pathways (TNF, IFNG), PPARG/A with gut-liver signaling pathways (FGF21, IGF1R, CREBP) and fatty acid and lipid oxidation in compensated cirrhosis versus controls (Fig. 5A).